Search

Home > OncLive® On Air > 1: FDA Approval Insights: Tivozanib in Relapsed/Refractory Advanced RCC
Podcast: OncLive® On Air
Episode:

1: FDA Approval Insights: Tivozanib in Relapsed/Refractory Advanced RCC
Category: Science & Medicine
Duration: 00:10:31
Publish Date: 2021-06-03 19:58:26
Description: Dr. Rini discusses unique elements of the TIVO-3 trial, the significance of the FDA approval of tivozanib in advanced RCC, and potential next steps for research with the TKI in the paradigm.
Total Play: 0

Some more Podcasts by Audioboom

70+ Episodes
Faith Moveme ..    
100+ Episodes
Videnskab.dk .. 5     1
20+ Episodes
Vidensselska ..    
10+ Episodes
Odd Jobs    
20+ Episodes
Aaron and Ga ..    
100+ Episodes
Ladies of Li .. 4     3
100+ Episodes
Chamber Podc ..    
10+ Episodes
IT'S A GROWN ..